| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Cattedra di Medicina Interna, Ospedale S Gerardo, Monza,
University of Milano (G.P., G.M.); Istituto Scientifico Ospedale S Luca,
Centro Auxologico Italiano, Milano (G.P., L.U., S.O., G.M.); Centro di
Fisiologia Clinica e Ipertensione, IRCCS, Ospedale Maggiore and University of
Milano (G.P., L.U., C.S., G.M.), Italy.
Correspondence to Dr Gianfranco Parati, Istituto Scientifico Ospedale S Luca, Via Spagnoletto 3, 20149 Milano, Italy. E-mail gparati{at}imiucca.csi.unimi.it
No demonstration has ever been given, however, that the clinic-daytime
blood pressure difference is due to a white coat effect and therefore
the term "white coat hypertension" is appropriate. In the
present study, we addressed this issue by measuring in the same
subjects the clinic-daytime blood pressure difference and the actual
pressor response to blood pressure measurements by a physician in the
clinic environment.
Measurements
Blood pressure also was continuously monitored for 45 minutes with a
finger device (Finapres 2300; Ohmeda), which was previously shown to
provide values similar to those obtained intra-arterially
from the radial artery and to accurately follow rapid and marked
changes of intra-arterial blood pressure induced with a
variety of stimuli.8 9 10 The device cuff was
wrapped around the mid or ring finger of the nondominant arm. The
finger blood pressure recording was performed in the outpatient
clinic with the patient in the supine position and the instrumented
hand positioned at the heart level. The device was calibrated at the
beginning of the recording by inducing stepwise changes in
pressure from 0 to 200 mm Hg through the device pump, which was
connected to a mercury column. The recording was started after
demonstration that (1) the average of three finger blood pressure
values agreed within ±7 mm Hg with the average of three values
taken simultaneously from the contralateral arm with a
mercury sphygmomanometer and (2) the between-arm blood pressure
difference was
Protocol
Data Analysis
Data from individual subjects were pooled and expressed as mean±SEM
for the group as a whole. The statistical significance of the
differences in mean values was assessed with a Student's t
test for paired observations. Correlations between direct and indirect
measures of the white coat effect were examined by computing Pearson's
correlation coefficient. A value of P<.05 was taken as the
level of statistical significance.
The 28 subjects showed a marked and persistent increase in finger
blood pressure during the physician's visits compared with the
measurements during the previsit and postvisit periods (Figs 1
Fig 4
Several aspects of the present study deserve discussion. First, it
can be suggested that the difference between the higher blood pressure
measured in the clinic environment and the lower pressure recorded
during the daytime was smaller and unrelated to the white coat effect
directly quantified through continuous finger blood pressure
recording because previous visits had made the patients less
reactive to sphygmomanometric measurements. However, (1) in our
patients, direct assessment of the white coat effect always followed
the visit in which clinic blood pressure was determined, (2) the
diagnosis of hypertension had been made only recently and all patients
were seen in our center for the first time, and (3) most importantly,
the clinic-daytime blood pressure difference is persistent over time
(G.P. and G.M., unpublished data from the Study on Ambulatory
Monitoring of Pressure and Lisinopril Evaluation
[SAMPLE]) and only slightly reduced with
treatment.7 12 Thus, it can be excluded that
habituation to sphygmomanometric measurements is responsible for a less
pronounced clinic-daytime blood pressure difference compared with the
directly measured white coat effect. Second, it also can be suggested
that the response of finger blood pressure to the physician's visit
was greater because of the anxiety inherent to the novelty of the
continuous blood pressure monitoring procedure. However, before the
physician's visit, finger blood pressure was by no means elevated.
Furthermore, and more importantly, in a previous study, we have shown
the white coat effect measured directly with continuous blood pressure
monitoring to be unchanged for several visits.5
Thus, that the procedure involved in the direct assessment of the white
coat effect caused an exaggerated finger blood pressure response can
also be excluded. Third, it can be suggested that the clinic-daytime
blood pressure difference originates from a white coat effect but fails
to reflect the actual size of this phenomenon because as reflected by
the lack of correlation between clinic blood pressure and the peak
increase in finger blood pressure during the physician's visit, clinic
blood pressure measurements seldom correspond to the variable time
at which blood pressure shows its maximal increase during the
physician's visit (see Fig 4
Three additional points deserve to be made. First, the white coat
effect directly measured with continuous finger blood pressure
recording is similar to the white coat effect previously
documented through intra-arterial blood pressure
monitoring.4 5 Thus, the white coat effect can
also be precisely quantified with a noninvasive
approach,19 allowing the direct investigation of
a number of important features of this phenomenon that have so far
remained unexplored (ie, differences among different hypertensive
subgroups, persistence or attenuation with time or different
antihypertensive treatments and prognostic significance). Second, the
observation that the difference between clinic and daytime blood
pressure does not reflect the white coat effect does not deny the
pathophysiological and clinical importance of this
finding in a hypertensive individual.20 21 22 It is
important, however, that the mechanisms responsible for this difference
are investigated by taking into account not only what increases clinic
blood pressure but also what modulates daily life blood pressure. It is
also important that its prognostic value is studied separately from the
prognostic value of the white coat effect. Its definition as white coat
hypertension should therefore be avoided because its origin is
different, whereas the clinical significance of the true white coat
phenomenon can now be directly investigated. Finally, studies on the
clinical significance of the true white coat phenomenon should take
into account that previous data obtained through
intra-arterial blood pressure monitoring have shown that
the blood pressure response to the physician's visit does not
correlate with the blood pressure responses to mental arithmetic, with
the responses to other laboratory stressors,23
and with daily life blood pressure variability.24
Thus, hyperreactivity to an emotional stimulus does not invariably mean
a generalized hyperreactivity to stress.
Received October 31, 1997;
first decision November 21, 1997;
accepted December 24, 1997.
2.
Mancia G. Presidential Lecture: Ambulatory blood
pressure monitoring: research and clinical applications. J
Hypertens. 1990;8(suppl 7):S1S13.
3.
Parati G, Pomidossi G, Albini F, Malaspina D, Mancia
G. Relationship of 24-hour blood pressure mean and variability to
severity of target organ damage in hypertension.
Hypertension. 1987;5:9398.
4.
Mancia G, Bertinieri G, Grassi G, Parati G, Pomidossi
G, Ferrari A, Gregorini L, Zanchetti A. Effects of blood pressure
measurements by the doctor on patient's blood pressure and heart rate.
Lancet.. 1983;2:695698.[Medline]
[Order article via Infotrieve]
5.
Mancia G, Parati G, Pomidossi G, Grassi G, Casadei R,
Zanchetti A. Alerting reaction and rise in blood pressure during
measurement by physician and nurse. Hypertension.. 1987;9:209215.
6.
Pickering TG, James GD, Boddie C, Harshfield GA, Blank
S, Laragh JH. How common is white coat hypertension? JAMA.. 1988;259:225228.
7.
Parati G, Omboni S, Mancia G. Difference between
office and ambulatory blood pressure and response to antihypertensive
treatment. J Hypertens.. 1996;14:791797.[Medline]
[Order article via Infotrieve]
8.
Parati G, Casadei R, Groppelli A, Di Rienzo M, Mancia
G. Comparison of finger and intra-arterial blood pressure
monitoring at rest and during laboratory test. Hypertension.. 1989;13:647655.
9.
Imholz BPM, Van Montfrans GA, Settels JS, Van
Der Hoeven GMA, Karemaker JM, Wieling N. Continuous non-invasive blood
pressure monitoring: reliability of Finapres device during the Valsalva
manoeuvre. Cardiovasc Res.. 1988;22:390397.[Medline]
[Order article via Infotrieve]
10.
Idema RN, Van der Meiracker AH, Imholz BPM, Man in't
Veld AJ, Ritsema van Eck HJ, Schalekamp MADH. Comparison of Finapres
non-invasive beat-to-beat finger blood pressure with intra-brachial
artery pressure during and after bicycle ergometry. J
Hypertens.. 1989;7:S58S59.
11.
Mancia G, Zanchetti A. White-coat hypertension:
misnomers, misconceptions and misunderstandings: what should we do
next? J Hypertens.. 1996;14:10491052.[Medline]
[Order article via Infotrieve]
12.
Myers MG, Reeves RA. White coat phenomenon in patients
receiving antihypertensive therapy. Am J Hypertens.. 1991;4:844849.[Medline]
[Order article via Infotrieve]
13.
Mancia G, Zanchetti A. Blood pressure variabilities.
In: Zanchetti A, Tarazi R, eds. Handbook of Hypertension, Vol 7:
Pathophysiology of Hypertension, Cardiovascular
Aspects. Amsterdam, Netherlands: Elsevier; 1986:125152.
14.
Mancia G, Ferrari A, Gregorini L, Parati G, Pomidossi
G, Bertinieri G, Grassi G, Di Rienzo M, Pedotti A, Zanchetti A. Blood
pressure and heart rate variabilities in normotensive and hypertensive
human beings. Circ Res.. 1983;53:96104.
15.
Mancia G, Di Rienzo M, Parati G. Ambulatory blood
pressure monitoring use in hypertension research and clinical practice.
Hypertension.. 1993;21:510522.
16.
Conway J, Coats A. Value of ambulatory blood pressure
monitoring in clinical pharmacology. J Hypertens.
1989;7(suppl 3):S29S32.
17.
Trazzi S, Mutti E, Frattola A, Imholz BM, Parati G,
Mancia G. Reproducibility of non-invasive and
intra-arterial blood pressure monitoring: implications for
studies on antihypertensive treatment. J Hypertens.. 1991;9:115119.[Medline]
[Order article via Infotrieve]
18.
Mancia G, Omboni S, Parati G, Trazzi S, Mutti E.
Limited reproducibility of hourly blood pressure values obtained by
ambulatory blood pressure monitoring: implications for studies on
antihypertensive drugs. J Hypertens.. 1992;10:15311535.[Medline]
[Order article via Infotrieve]
19.
Parati G, Omboni S, Mancia G. Experience with
continuous non-invasive finger blood pressure monitoring: a new
research tool. Homeostasis Health Dis.. 1995;36:139152.
20.
Julius S, Mejia A, Jones K, Krause L, Shork N, ven de
Ven C, Johnson E, Petrin J, Sekkarie MA, Kjeldsen SE, Schmouder R,
Gupta R, Ferraro J, Nazzaro P, Weissfeld J. `White coat' versus
`sustained' borderline hypertension in Tecumseh, Michigan.
Hypertension.. 1990;16:617623.
21.
Gosse P, Promax H, Durandet P, Clementy J. `White
coat' hypertension: no harm for the heart. Hypertension.. 1993;22:766770.
22.
Kuwajima I, Suzuki J, Fujisawa A, Kuramoto K. Is white
coat hypertension innocent? Structure and function of the heart in the
elderly. Hypertension.. 1993;22:826831.
23.
Parati G, Pomidossi G, Casadei R, Ravogli A, Groppelli
A, Cesana B, Mancia G. Comparison of the cardiovascular
effects of different laboratory stressors and their relationship with
blood pressure variability. J Hypertens.. 1988;6:481488.[Medline]
[Order article via Infotrieve]
24.
Mancia G, Parati G. Reactivity to physical and
behavioral stress and blood pressure variability in hypertension. In:
Julius S, Bassett DS, eds. Handbook of Hypertension, Vol
9. Amsterdam, Netherlands: Elsevier; 1987:104122.
© 1998 American Heart Association, Inc.
Scientific Contributions
Difference Between Clinic and Daytime Blood Pressure Is Not a Measure of the White Coat Effect
![]()
Abstract
Top
Abstract
Introduction
Methods
Results
Discussion
References
AbstractThe purpose of the
present study was to evaluate whether the difference between blood
pressure measured in the clinic or physician's office and the average
daytime blood pressure accurately reflects the blood pressure response
of the patient to the physician ("white coat effect" or "white
coat hypertension"). We studied 28 hypertensive outpatients (mean
age, 41.8±11.2 years; age range, 21 to 64 years) of 35 consecutive
patients attending our hypertension clinic, in whom (1) continuous
noninvasive finger blood pressure was recorded before and during
the visit, (2) blood pressure was measured according to the
Riva-Rocci-Korotkoff method (mercury sphygmomanometer) with the patient
in the supine position, and (3) daytime ambulatory blood pressure was
monitored with a SpaceLabs 90207 device. The peak blood pressure
increase recorded directly during the visit was compared with the
difference between clinic and daytime average ambulatory blood
pressures. Compared with previsit values, peak increases in finger
systolic and diastolic blood pressures during the
visit to the clinic were 38.2±3.1 and 20.7±1.6 mm Hg,
respectively (mean±SEM, P<.01 for both). Daytime
average systolic and diastolic blood pressures were
135.5±2.5 and 89.2±1.9 mm Hg, with both lower than the
corresponding clinic blood pressure values (146.6±3.6 and
94.9±2.2 mm Hg, P<.01). These differences,
however, were <30% of the peak finger blood pressure increases during
the physician's visit, to which these increases showed no relation.
Although the visit to the physician's office was associated with
tachycardia (9.0±1.6 bpm, P<.01), there
was no difference between clinic and daytime average heart rates. These
data indicate that the clinic-daytime average blood pressure
difference does not reflect the alerting reaction and the pressure
response elicited by the physician's visit and thus is not a reliable
measure of the white coat effect.
Key Words: blood pressure monitoring, ambulatory stress risk factors hypertension, white coat blood pressure
![]()
Introduction
Top
Abstract
Introduction
Methods
Results
Discussion
References
Ambulatory blood
pressure monitoring has shown that in most subjects, daytime blood
pressure is lower than clinic blood pressure.1 2 3
This difference is ascribed to the "white coat effect" (ie, the
alerting reaction and pressor response of the patient to the
measurement of blood pressure in the clinic
environment).4 5 As a result, subjects with a
clinic blood pressure of >140/90 mm Hg and a daytime blood
pressure below this value are called "white coat
hypertensives."6 7
![]()
Methods
Top
Abstract
Introduction
Methods
Results
Discussion
References
Subjects
Thirty-five hypertensive patients were considered for inclusion
in the study. Seven of the patients were not included in the
analysis because of poor-quality ambulatory (n=3) or finger
(n=1) blood pressure recording or because of frequent cardiac
arrhythmias (n=3), which prevented an accurate blood pressure
monitoring from being obtained. Thus, the study population consisted of
28 outpatients (10 men and 18 women) with an age range of 21 to 64
years (mean±SD age, 41.8±11.2 years). All patients were seen for the
first time in our outpatient center because of the recent detection of
blood pressure elevation during a visit with their family physician.
The patients were recruited if they had mild essential hypertension
(ie, clinic diastolic blood pressure [average of three
values] of 91 to 104 mm Hg). Patients were untreated or had
their antihypertensive treatment withdrawn for 3 weeks. Additional
inclusion criteria were no history or evidence of cerebrovascular,
cardiac, or renal complications or damage; no serious concomitant
cardiovascular or noncardiovascular
disease; no major arrhythmias; body mass index of <27
kg/m2; and evidence of a good-quality finger
blood pressure signal (see below) at a preliminary recording
session held in the outpatient clinics. The patients consented to the
procedure after information was provided that their blood pressure was
going to be measured through different techniques to more fully
characterize their hypertensive condition. The study protocol was
approved by the ethics committee of the institutions involved.
Blood pressure measurements made were those often used for
hypertensive patients at our clinic. Clinic blood pressure was obtained
from the nondominant arm with a mercury sphygmomanometer; the first and
fifth Korotkoff sounds were taken to identify systolic and
diastolic values, respectively. Heart rate was measured
according to the palpatory method (30 seconds) after the blood pressure
measurement was made. Ambulatory blood pressure recording was
obtained for 24 hours with a SpaceLabs 90207 device; the cuff was
applied to the nondominant arm. The ambulatory recording was
started at
10 AM in the outpatient clinic, after the
demonstration that the average of three blood pressure values provided
with use of the SpaceLabs device agreed within ±5 mm Hg with the
average of three values taken simultaneously from the same
arm by the auscultatory method via a Y tube connected to a mercury
column. The device was set to allow automatic blood pressure
measurements every 15 minutes from 7 AM to 11
PM and every 20 minutes from 11 PM to 7
AM. All recordings were performed on working days
(Monday through Friday). The subjects were instructed to attend to
their usual activity during the recording period and to return
to the outpatient clinic the following morning for device
removal.
±5 mm Hg.
The study began with a visit by a physician unknown to the
patients to measure clinic blood pressure (and heart rate) with the
patient in the supine position for 5 minutes. The visit started with a
brief patient history and included three sphygmomanometric blood
pressure and three heart rate measurements at minutes 3, 5, and 8 of a
15-minute period. It also included a physical examination focused on
the cardiovascular system, which was performed in the
final minutes of the visit. All patients then underwent the 24-hour
ambulatory blood pressure monitoring and the 45-minute finger blood
pressure recording, which were obtained within 1 week of the
initial visit with a 1- to 2-day interval between each other. To obtain
a direct measure of the white coat effect during the 45-minute
recording period, the supine patients were visited by another
physician they had not previously met. The physician was instructed to
measure blood pressure with a mercury sphygmomanometer according to the
procedure adopted routinely for hypertensive patients. The visit lasted
15 minutes, and measurements were made at minutes 3, 5, 8, 11, and 13
of the visit. The sphygmomanometric values determined by the physician
on this visit were not used to calculate the "clinic" blood
pressure value (which was based on the sphygmomanometric values of the
first visit) but were used to determine whether the peak finger blood
pressure rise during the visit might coincide with any of the time
during which sphygmomanometry was used. In 14 patients, ambulatory
blood pressure monitoring preceded the 45-minute finger blood pressure
recording period, whereas in the remaining 14 patients,
monitoring followed the period.
In each patient, the three clinic systolic blood
pressure, diastolic blood pressure, and heart rate
measurements obtained during the initial visit were averaged and
referred to as the "clinic blood pressure and heart rate."
Systolic blood pressure, diastolic blood pressure,
and heart rate values obtained with ambulatory monitoring during the
daytime also were averaged. The daytime period was defined as the
period between 7 and 11 AM during which the subject's
diary indicated the subject was awake. Finger blood pressure data were
recorded (Racal Recorders) and analyzed. First, the analog
blood pressure signal was sampled at 168 Hz, converted with a precision
of 12 bits, and stored on a computer disk. Second, systolic and
diastolic blood pressures were computed for each blood
pressure wave, and heart rate was derived as the reciprocal of the
interval between consecutive systolic peaks. Third,
beat-to-beat values were averaged for each minute of the 45-minute
recording. Fourth, average values were obtained for the
10-second period showing the maximal increase in both systolic
and diastolic blood pressures during the visit and a
10-second period during the 5 minutes before the visit. The
corresponding 10-second heart rate values also were calculated. The
differences between clinic and average daytime values were taken as the
traditional (and indirect) measure of the white coat effect. Direct
assessment of the white coat effect was obtained by computing the
differences between peak 10-second finger blood pressure values during
the visit and the 10-second values before the visit.
![]()
Results
Top
Abstract
Introduction
Methods
Results
Discussion
References
For the 28 subjects, average clinic systolic and
diastolic blood pressures were 146.6±3.6 and
94.9±2.2 mm Hg, respectively. Corresponding daytime values were
significantly lower (135.5±2.5 and 89.2±1.9, P<.01), and
the averages of the individual clinic-daytime differences were
11.1±3.5 (systolic) and 5.7±2.4 (diastolic)
mm Hg. Thus, according to the conventional indirect approach used with
these subjects, there was a noticeable average white coat effect.
and 2
).
In most subjects, however, the magnitude of the peak finger blood
pressure increase (ie, directly measured white coat effect) was
considerably greater than the white coat effect indirectly quantified
as the difference between clinic blood pressure (average of three
values) and daytime blood pressure. On average, the peak finger blood
pressure increase was 38.2±3.1 mm Hg for systolic blood
pressure and 20.7±1.6 mm Hg for diastolic blood
pressure, with values more than threefold the average clinic-daytime
blood pressure differences (Fig 3
, top).
The peak increase in finger blood pressure directly recorded during
the physician's visit and the clinic-daytime blood pressure
differences also were not significantly related to each other (Fig 3
, bottom). This was also true for the corresponding heart rate values.
Indeed, although when directly recorded, heart rate showed an
average clear-cut increase during the physician's visit, clinic heart
rate was on average lower than daytime heart rate (Figs 1 through 3![]()
![]()
).

View larger version (30K):
[in a new window]
Figure 1. Original finger blood pressure and heart rate
tracing showing the pressor and tachycardic effects of the physician's
visit in a representative subject. The segment of blood
pressure and heart rate tracing between vertical bars corresponds to
the time of physician's visit.

View larger version (30K):
[in a new window]
Figure 2. Blood pressure (BP) and heart rate (HR) effects of
the physician's visit. Data are shown as average±SEM 1-minute values
of a 15-minute period before the visit, the 15-minute visit (between
vertical lines), and a 10-minute period after the visit for the entire
group of 28 patients. Systolic (S) and diastolic
(D) 1-minute averages are illustrated separately.

View larger version (17K):
[in a new window]
Figure 3. Comparison between the clinic-average daytime
blood pressure (BP) difference (CBP-ABP) and the increase in BP and
heart rate (HR) directly measured during the physician's visit (white
coat effect [WCE]) (n=28). Both individual and average±SEM group
data are shown separately for systolic BP (SBP),
diastolic BP (DBP), and HR (top). Bottom, Lack of a
significant within-subject correlation between CBP-ABP and WCE values.
**Statistical significance of the differences between the two sets
of values (P<.01).
shows the timing of the peak blood
pressure response measured directly during the physician's visit. Peak
changes occurred at a variable time during the visit, and only in a
small number of subjects did they coincide with one of the five
sphygmomanometric blood pressure measurements made during the visit.
This was reflected by the lack of correlation between the peak increase
in finger systolic blood pressure during the physician's visit
and the average or highest sphygmomanometric systolic blood
pressure value obtained for the visit during which clinic blood
pressure was determined (r=.23 and .20, respectively;
P=NS). Similar results were obtained for
diastolic blood pressure (r=.25 and .20,
respectively; P=NS).

View larger version (37K):
[in a new window]
Figure 4. Timing of the maximal increase in both
systolic and diastolic finger blood pressure during
the physician's visit. Vertical bars indicate number of subjects
showing a maximal blood pressure increase during the 15-minute visit;
arrows, timing of cuff blood pressure measurements by the
physician.
![]()
Discussion
Top
Abstract
Introduction
Methods
Results
Discussion
References
In our subjects, the increase in blood pressure triggered by the
visit of an unfamiliar physician in charge of measuring blood pressure
was greater than the difference between conventional clinic and daytime
average blood pressures. Furthermore, the physician-dependent increase
in blood pressure and the clinic-daytime blood pressure difference
showed no relation to each other when clinic blood pressure was
obtained with an average of three values and when the highest
clinic value was considered. Finally, although the increase in blood
pressure triggered by the physician was accompanied by a sizable
tachycardia, clinic heart rate was on average lower than
daytime heart rate. These findings provide evidence that the
clinic-daytime blood pressure difference does not reliably reflect the
alerting reaction and the pressure response elicited in the patient by
blood pressure measurement by a physician. Taking this difference as a
measure of the white coat effect is therefore erroneous. It
consequently is also erroneous to call patients white coat
hypertensives if they have a clinic blood pressure of
>140/90 mm Hg and a daytime ambulatory blood pressure of
<140/90 mm Hg or any other arbitrary blood pressure level. A
more appropriate term for these subjects should be the descriptive term
"isolated clinic hypertensives."11
). It should be emphasized, however, that
the true white coat effect differed from the clinic-daytime blood
pressure difference not only quantitatively but also qualitatively (ie,
although the true white coat effect was accompanied by
tachycardia, the clinic-daytime heart rate difference was
if anything a negative difference). We thus believe that another
possibility is most likely, namely that the clinic-daytime blood
pressure difference originates not so much from a greater or lesser
effect of emotion on clinic blood pressure but rather from factors that
modulate daily life blood pressure level and lead to an increase or
reduction in daytime blood pressure that may differ among
subjects.13 14 15 Another possibility, which is not
exclusive of the above possibility, is that, of course, as an average
of a large number of values, daytime blood pressure achieves an
immediate regression to the mean.7 16 17 A third
possibility is that a greater concordance between the true white coat
effect and its surrogate measure could be obtained by considering only
the ambulatory values around the time at which the visit was made.
However, this procedure would be opened to the disadvantage that
ambulatory blood pressure within a limited time window has a poor and
varying reproducibility.18 Furthermore, in our
study, as in most surrogate assessments of the white coat effect,
clinic blood pressure and ambulatory blood pressure were obtained on
different days.
![]()
References
Top
Abstract
Introduction
Methods
Results
Discussion
References
1.
Sokolow M, Werdegar S, Kain H, Hinman AT. A
relationship between level of blood pressure measured casually and by
portable recorders and severity of complications in essential
hypertension. Circulation.. 1966;34:279298.
This article has been cited by other articles:
![]() |
S. E. Kjeldsen, T. A. Aksnes, R. H. Fagard, and G. Mancia CHAPTER 13 Hypertension ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF] |
||||
![]() |
Authors/Task Force Members:, G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, G. Germano, G. Grassi, A. M. Heagerty, S. E. Kjeldsen, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur. Heart J., June 11, 2007; (2007) ehm236v1. [Full Text] [PDF] |
||||
![]() |
P. W. Franks White-Coat Hypertension and Risk of Stroke: Do the Data Really Tell Us What We Need to Know? Hypertension, February 1, 2005; 45(2): 183 - 184. [Full Text] [PDF] |
||||
![]() |
P. Verdecchia, F. Angeli, and R. Gattobigio Clinical Usefulness of Ambulatory Blood Pressure Monitoring J. Am. Soc. Nephrol., January 1, 2004; 15(90010): S30 - 33. [Abstract] [Full Text] |
||||
![]() |
W. T Hamilton, D. Sharp, T. Marshall, P. Palatini, M. Brueren, and A. Bissery Comparison of different measures of blood pressure BMJ, December 7, 2002; 325(7376): 1360 - 1360. [Full Text] |
||||
![]() |
G. Mancia and G. Parati Ambulatory Blood Pressure Monitoring and Organ Damage Hypertension, November 1, 2000; 36(5): 894 - 900. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Mancia White coat effect. Innocuous or adverse phenomenon? Eur. Heart J., October 2, 2000; 21(20): 1647 - 1648. [PDF] |
||||
![]() |
P. Verdecchia Prognostic Value of Ambulatory Blood Pressure : Current Evidence and Clinical Implications Hypertension, March 1, 2000; 35(3): 844 - 851. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Parati, L. Ulian, L. Sampieri, P. Palatini, A. Villani, A. Vanasia, and G. Mancia Attenuation of the "White-Coat Effect" by Antihypertensive Treatment and Regression of Target Organ Damage Hypertension, February 1, 2000; 35(2): 614 - 620. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Fossum, A. Hoieggen, A. Moan, M. Rostrup, and S. E. Kjeldsen Insulin Sensitivity Is Related to Physical Fitness and Exercise Blood Pressure to Structural Vascular Properties in Young Men Hypertension, March 1, 1999; 33(3): 781 - 786. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |